IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 212 filers reported holding IMMUNOMEDICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $458,000 | +129.0% | 5,388 | -4.4% | 0.00% | +100.0% |
Q2 2020 | $200,000 | -86.8% | 5,634 | -95.0% | 0.00% | -87.5% |
Q1 2020 | $1,519,000 | -34.5% | 112,684 | +2.8% | 0.01% | -11.1% |
Q4 2019 | $2,319,000 | +58.2% | 109,598 | -0.8% | 0.01% | +50.0% |
Q3 2019 | $1,466,000 | -5.1% | 110,522 | -0.7% | 0.01% | 0.0% |
Q2 2019 | $1,544,000 | -15.9% | 111,291 | +16.4% | 0.01% | -14.3% |
Q1 2019 | $1,837,000 | +32.9% | 95,640 | -1.3% | 0.01% | +16.7% |
Q4 2018 | $1,382,000 | -29.6% | 96,876 | +2.7% | 0.01% | -14.3% |
Q3 2018 | $1,964,000 | -3.3% | 94,284 | +9.8% | 0.01% | 0.0% |
Q2 2018 | $2,032,000 | +112.8% | 85,863 | +31.4% | 0.01% | +133.3% |
Q1 2018 | $955,000 | -14.2% | 65,343 | -5.1% | 0.00% | -25.0% |
Q4 2017 | $1,113,000 | +16.2% | 68,857 | +0.5% | 0.00% | +33.3% |
Q3 2017 | $958,000 | +71.1% | 68,533 | +8.1% | 0.00% | +50.0% |
Q2 2017 | $560,000 | +46.6% | 63,408 | +7.3% | 0.00% | +100.0% |
Q1 2017 | $382,000 | +107.6% | 59,094 | +17.8% | 0.00% | 0.0% |
Q4 2016 | $184,000 | -99.9% | 50,184 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $163,521,000 | +40.3% | 50,314 | +0.2% | 0.00% | – |
Q2 2016 | $116,550,000 | -17.3% | 50,237 | -11.1% | 0.00% | -100.0% |
Q1 2016 | $141,000,000 | -18.5% | 56,498 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $173,000,000 | +178250.5% | 56,498 | -0.2% | 0.00% | – |
Q3 2015 | $97,000 | -100.0% | 56,596 | -52.7% | 0.00% | -100.0% |
Q2 2015 | $485,666,000 | +143.9% | 119,622 | +130.1% | 0.00% | +100.0% |
Q1 2015 | $199,129,000 | -22.6% | 51,992 | -3.0% | 0.00% | 0.0% |
Q4 2014 | $257,300,000 | +24.3% | 53,604 | -3.7% | 0.00% | 0.0% |
Q3 2014 | $207,063,000 | +1.8% | 55,662 | -0.1% | 0.00% | 0.0% |
Q2 2014 | $203,313,000 | -3.1% | 55,702 | +11.7% | 0.00% | 0.0% |
Q1 2014 | $209,864,000 | -6.2% | 49,849 | +2.5% | 0.00% | 0.0% |
Q4 2013 | $223,799,000 | -26.4% | 48,652 | -1.0% | 0.00% | -50.0% |
Q3 2013 | $304,177,000 | +12.6% | 49,140 | -1.1% | 0.00% | 0.0% |
Q2 2013 | $270,199,000 | – | 49,669 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |